{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-004805","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.824275+00:00","generated_at":"2026-06-07T01:39:56.844329+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Cytek Biosciences prelim FY2023 revenue near high end of $188M-$192M guidance","bullets":["Preliminary full-year 2023 revenue expected near high end of prior guidance range of $188M-$192M.","Final Q4 and FY2023 results and 2024 guidance to be reported on expected earnings call in late February 2024.","CEO Wenbin Jiang to present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-004805","json":"https://secwatch.observer/filing/0001193125-24-004805.json","markdown":"https://secwatch.observer/filing/0001193125-24-004805.md","text":"https://secwatch.observer/filing/0001193125-24-004805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524004805/0001193125-24-004805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524004805/d690054d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:39:56.844329+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b18946e99298e38588c32fcb47e6a2d6adfa6ff8","claim":"Cytek Biosciences, Inc. reported preliminary financial results for the full year ended December 31, 2023.","evidence_excerpt":"Cytek expects its full year revenue for 2023 to be near the high end of the company’s most recent revenue guidance range of $188 million to $192 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524004805/0001193125-24-004805-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}